Cargando…

Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study

BACKGROUND: Peroxisome proliferators-activated receptor alpha (PPARα) activation modulates cholesterol metabolism and suppresses bile acid synthesis. This study aims to evaluate the effect of short-term administration of fenofibrate, a PPARα agonist, on proinflammatory cytokines, apoptosis, and hepa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cindoruk, Mehmet, Kerem, Mustafa, Karakan, Tarkan, Salman, Bulent, Akin, Okan, Alper, Murat, Erdem, Ozlem, Ünal, Selahattin
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219993/ https://www.ncbi.nlm.nih.gov/pubmed/18045488 http://dx.doi.org/10.1186/1471-230X-7-44

Ejemplares similares

Risk of Malignancy Using the Diagnostic Categories Proposed by the World Health Organization International System for Reporting Pancreaticobiliary Cytopathology
por: Gocun, Pınar Uyar, et al.
Publicado: (2022)

Fibrinogen storage disease without hypofibrinogenemia associated with estrogen therapy
por: Simsek, Z, et al.
Publicado: (2005)

The rare presentations of a large polyp and an esophageal carcinoma in heterotropic gastric mucosa: a case series
por: Alagozlu, Hakan, et al.
Publicado: (2007)

The synergistic ameliorative activity of peroxisome proliferator‐activated receptor‐alpha and gamma agonists, fenofibrate and pioglitazone, on hippocampal neurodegeneration in a rat model of insulin resistance
por: Idowu, Olumayowa K., et al.
Publicado: (2022)

Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol induced steatohepatitis in mice
por: Kong, Lingbo, et al.
Publicado: (2011)

Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis
por: McFarland, Lynne V., et al.
Publicado: (2021)

Hepatocellular proliferation in response to agonists of peroxisome proliferator-activated receptor alpha: a role for kupffer cells?
por: Alsarra, Ibrahim A, et al.
Publicado: (2006)

Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy
por: Deng, Guotao, et al.
Publicado: (2017)

Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice
por: Nan, Yue-Min, et al.
Publicado: (2013)

Low-Dose Lactulose as a Prebiotic for Improved Gut Health and Enhanced Mineral Absorption
por: Karakan, Tarkan, et al.
Publicado: (2021)

The Correlation Between Peroxisome Proliferator-Activated Receptor Alpha and Gamma Polymorphisms and Acute Coronary Syndrome
por: Kemanci, Aykut, et al.
Publicado: (2022)

The effect of Farnesoid X receptor agonist tropifexor on liver damage in rats with experimental obstructive jaundice
por: Kilavuz, Huseyin, et al.
Publicado: (2021)

Spindle Cell Carcinoma of the Tongue: A Rare Tumor in an Unusual Location
por: Oktay, Murat, et al.
Publicado: (2011)

Intestinal Endotoxins as Co-Factors of Liver Injury in Obstructive Jaundice
por: Menteş, B. Bülent, et al.
Publicado: (1996)

Transplacental induction of fatty acid oxidation in term fetal pigs by the peroxisome proliferator-activated receptor alpha agonist clofibrate
por: Lin, Xi, et al.
Publicado: (2015)

Anti-kindling Effect of Bezafibrate, a Peroxisome Proliferator-activated Receptors Alpha Agonist, in Pentylenetetrazole Induced Kindling Seizure Model
por: Saha, Lekha, et al.
Publicado: (2014)

The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats
por: Stunes, Astrid K, et al.
Publicado: (2011)

The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes
por: Thomas, M. C., et al.
Publicado: (2012)

The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
por: Li, Jingjing, et al.
Publicado: (2021)

Artificial intelligence-based personalized diet: A pilot clinical study for irritable bowel syndrome
por: Karakan, Tarkan, et al.
Publicado: (2022)

Peroxisome Proliferator-Activated Receptor Alpha Target Genes
por: Rakhshandehroo, Maryam, et al.
Publicado: (2010)

WY-14643, a Potent Peroxisome Proliferator Activator Receptor-α PPAR-α Agonist Ameliorates the Inflammatory Process Associated to Experimental Periodontitis
por: Briguglio, Enrico, et al.
Publicado: (2010)

Succinivibrionaceae is dominant family in fecal microbiota of Behçet’s Syndrome patients with uveitis
por: Tecer, Duygu, et al.
Publicado: (2020)

Jaundice
Publicado: (1860)

Peroxisome Proliferator-Activated Receptor Agonists: Do They Increase Cardiovascular Risk?
por: Aljada, Ahmad, et al.
Publicado: (2009)

Repurposing Peroxisome Proliferator-Activated Receptor Agonists in Neurological and Psychiatric Disorders
por: Sagheddu, Claudia, et al.
Publicado: (2021)

Gut-Brain-Microbiota Axis: Antibiotics and Functional Gastrointestinal Disorders
por: Karakan, Tarkan, et al.
Publicado: (2021)

Correlation between thyroid hormone status and hepatic hyperplasia and hypertrophy caused by the peroxisome proliferator-activated receptor alpha agonist Wy-14,643
por: Wang, C, et al.
Publicado: (2004)

Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model
por: Nakano, Yuji, et al.
Publicado: (2020)

Molecular Biological and Clinical Understanding of the Statin Residual Cardiovascular Disease Risk and Peroxisome Proliferator-Activated Receptor Alpha Agonists and Ezetimibe for Its Treatment
por: Yanai, Hidekatsu, et al.
Publicado: (2022)

L-Carnitine ameliorates the liver by regulating alpha-SMA, iNOS, HSP90, HIF-1alpha, and RIP1 expressions of CCL4-toxic rats
por: Karabulut, Derya, et al.
Publicado: (2021)

Enhanced Hepatocarcinogenicity Due to Agonists of Peroxisome Proliferator-Activated Receptors in Senescent Rats: Role of Peroxisome Proliferation, Cell Proliferation, and Apoptosis
por: Youssef, Jihan, et al.
Publicado: (2002)

Adaptation of peroxisome proliferator-activated receptor alpha to hibernation in bats
por: Han, Yijie, et al.
Publicado: (2015)

The peroxisome proliferator-activated receptor gamma (PPARγ) agonist, rosiglitazone, ameliorates neurofunctional and neuroinflammatory abnormalities in a rat model of Gulf War Illness
por: Keledjian, Kaspar, et al.
Publicado: (2020)

The effect of Ankaferd blood stopper on liver damage in experimental obstructive jaundice
por: KOŞMAZ, Koray, et al.
Publicado: (2021)

Peroxisome proliferator-activated receptor alpha agonist suppresses neovascularization by reducing both vascular endothelial growth factor and angiopoietin-2 in corneal alkali burn
por: Arima, Takeshi, et al.
Publicado: (2017)

Beneficial outcomes of glucagon like peptide-1 agonist therapy in a patient with Bardet Biedl syndrome and kidney transplant
por: Erturk, Banu, et al.
Publicado: (2023)

Suppression of Rat Oral Carcinogenesis by Agonists of Peroxisome Proliferator Activated Receptor γ
por: McCormick, David L., et al.
Publicado: (2015)

Synergy between peroxisome proliferator‐activated receptor γ agonist and radiotherapy in cancer
por: Huang, Guodong, et al.
Publicado: (2018)

Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
por: Fruchart, Jean-Charles
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_oq2e2qvdctdloqq1et0qf74gu7